Ubs Asset Management Americas Inc Rocket Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 139,572 shares of RCKT stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

139,572

Previous 119,633 16.67%

Holding current value

$1.22 Million

Previous $2.21 Million 20.6%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$11.35 - $18.82 $226,307 - $375,251	19,939 Added 16.67%	139,572 $1.75 Million
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $27,473 - $40,398	1,561 Added 1.32%	119,633 $2.21 Million
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $1.08 Million - $1.4 Million	52,282 Added 79.47%	118,072 $2.54 Million
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $136,581 - $160,493	-5,221 Reduced 7.35%	65,790 $1.77 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $349,711 - $665,661	20,841 Added 41.54%	71,011 $2.13 Million
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $278,779 - $444,900	18,499 Added 58.41%	50,170 $1.03 Million
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $344,222 - $492,680	-21,800 Reduced 40.77%	31,671 $542,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $222,161 - $326,219	14,333 Added 36.62%	53,471 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $179,519 - $300,478	-8,342 Reduced 17.57%	39,138 $854,000
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $37,620 - $67,186	-1,372 Reduced 2.81%	47,480 $1.42 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $453,687 - $543,942	11,512 Added 30.83%	48,852 $2.16 Million
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $81,002 - $123,185	1,869 Added 5.27%	37,340 $1.66 Million
Q3 2020 Nov 13, 2020	BUY	$20.5 - $28.59 $83,640 - $116,647	4,080 Added 13.0%	35,471 $810,000
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $418,128 - $709,750	31,391 New	31,391 $657,000
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $91,409 - $236,385	-9,414 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $104,212 - $228,101	9,414 New	9,414 $214,000
Q3 2019 Nov 14, 2019	SELL	$10.85 - $14.78 $134,952 - $183,833	-12,438 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$15.0 - $19.81 $186,570 - $246,396	12,438 New	12,438 $0

Others Institutions Holding RCKT

# of Institutions

243

Shares Held

94.3M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $661M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Rocket Pharmaceuticals, Inc. Transaction History